1. Home
  2. ICD-10-CM MS-DRG V42.0
  3. Diagnosis Codes in MS-DRG 810 - Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders Without CC/MCC

Diagnosis Codes in MS-DRG 810 - Major Hematological And Immunological Diagnoses Except Sickle Cell Crisis And Coagulation Disorders Without CC/MCC

The Medicare Severity Diagnosis-Related Group (MS-DRG) is a patient classification system used to categorize hospital cases based on clinical similarity and expected resource use. MS-DRGs organize all possible principal diagnoses into mutually exclusive groups known as Major Diagnostic Categories (MDCs), which help determine reimbursement under the Medicare Inpatient Prospective Payment System.

This section lists the diagnosis codes included in MS-DRG V42.0: Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders without CC/MCC from October 1, 2024, through September 30, 2025.

MS-DRG: 810

MS-DRG Title: Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders without CC/MCC

MCD: 16

Relative Weight: 0.9517 Relative Weight
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.

Geometric LOS: 0.95 Geometric Length of Stay
The geometric mean length of stay (GMLOS) is used by Medicare to calculate the reimbursement for patients whose medical treatment takes a much longer or shorter time than average.

Arithmetic LOS: 2.50 Arithmetic Length of Stay
The average length of stay (ALOS) reflects the average number of days a patient spends in a hospital for each admission.

  • -

    • D71 - Functional disorders of polymorphonuclear neutrophils

  • D59 - Acquired hemolytic anemia

    • D59.0 - Drug-induced autoimmune hemolytic anemia

    • D59.2 - Drug-induced nonautoimmune hemolytic anemia

    • D59.4 - Other nonautoimmune hemolytic anemias

    • D59.5 - Paroxysmal nocturnal hemoglobinuria [Marchiafava-Micheli]

    • D59.6 - Hemoglobinuria due to hemolysis from other external causes

    • D59.8 - Other acquired hemolytic anemias

    • D59.9 - Acquired hemolytic anemia, unspecified

  • D59.1 - Other autoimmune hemolytic anemias

    • D59.10 - Autoimmune hemolytic anemia, unspecified

    • D59.11 - Warm autoimmune hemolytic anemia

    • D59.12 - Cold autoimmune hemolytic anemia

    • D59.13 - Mixed type autoimmune hemolytic anemia

    • D59.19 - Other autoimmune hemolytic anemia

  • D60 - Acquired pure red cell aplasia [erythroblastopenia]

    • D60.0 - Chronic acquired pure red cell aplasia

    • D60.1 - Transient acquired pure red cell aplasia

    • D60.8 - Other acquired pure red cell aplasias

    • D60.9 - Acquired pure red cell aplasia, unspecified

  • D61 - Other aplastic anemias and other bone marrow failure syndromes

    • D61.1 - Drug-induced aplastic anemia

    • D61.2 - Aplastic anemia due to other external agents

    • D61.3 - Idiopathic aplastic anemia

    • D61.9 - Aplastic anemia, unspecified

  • D61.0 - Constitutional aplastic anemia

    • D61.01 - Constitutional (pure) red blood cell aplasia

    • D61.02 - Shwachman-Diamond syndrome

    • D61.03 - Fanconi anemia

    • D61.09 - Other constitutional aplastic anemia

  • D61.8 - Other specified aplastic anemias and other bone marrow failure syndromes

    • D61.89 - Other specified aplastic anemias and other bone marrow failure syndromes

  • D61.81 - Pancytopenia

    • D61.810 - Antineoplastic chemotherapy induced pancytopenia

    • D61.811 - Other drug-induced pancytopenia

    • D61.818 - Other pancytopenia

  • D70 - Neutropenia

    • D70.0 - Congenital agranulocytosis

    • D70.1 - Agranulocytosis secondary to cancer chemotherapy

    • D70.2 - Other drug-induced agranulocytosis

    • D70.3 - Neutropenia due to infection

    • D70.4 - Cyclic neutropenia

    • D70.8 - Other neutropenia

    • D70.9 - Neutropenia, unspecified

  • D72 - Other disorders of white blood cells

    • D72.0 - Genetic anomalies of leukocytes

  • D80 - Immunodeficiency with predominantly antibody defects

    • D80.6 - Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia

    • D80.8 - Other immunodeficiencies with predominantly antibody defects

    • D80.9 - Immunodeficiency with predominantly antibody defects, unspecified

  • D81 - Combined immunodeficiencies

    • D81.0 - Severe combined immunodeficiency [SCID] with reticular dysgenesis

    • D81.1 - Severe combined immunodeficiency [SCID] with low T- and B-cell numbers

    • D81.2 - Severe combined immunodeficiency [SCID] with low or normal B-cell numbers

    • D81.4 - Nezelof's syndrome

    • D81.6 - Major histocompatibility complex class I deficiency

    • D81.7 - Major histocompatibility complex class II deficiency

    • D81.9 - Combined immunodeficiency, unspecified

  • D81.8 - Other combined immunodeficiencies

    • D81.82 - Activated Phosphoinositide 3-kinase Delta Syndrome [APDS]

    • D81.89 - Other combined immunodeficiencies

  • D82 - Immunodeficiency associated with other major defects

    • D82.0 - Wiskott-Aldrich syndrome

    • D82.1 - Di George's syndrome

  • D89.81 - Graft-versus-host disease

    • D89.810 - Acute graft-versus-host disease

    • D89.811 - Chronic graft-versus-host disease

    • D89.812 - Acute on chronic graft-versus-host disease

    • D89.813 - Graft-versus-host disease, unspecified

  • T86.0 - Complications of bone marrow transplant

    • T86.00 - Unspecified complication of bone marrow transplant

    • T86.01 - Bone marrow transplant rejection

    • T86.02 - Bone marrow transplant failure

    • T86.03 - Bone marrow transplant infection

    • T86.09 - Other complications of bone marrow transplant